Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Gametocyte development protein 3 (MD3) is a cytoplasmic CCCH zinc finger protein found in immature male gametocytes of Plasmodium falciparum. It plays a crucial regulatory role in male gametocytogenesis by interacting with an array of other RNA-binding proteins, including translational regulators (eIF4G, PUF1, NOT1, CITH) and further regulators of gametocyte differentiation (ZNF4, MD1, GD1). MD3 is necessary for proper gametocyte maturation, and parasites lacking MD3 exhibit substantial impairment in the development of male gametocytes.
Not directly targeted by drugs yet; inactivation or deficiency leads to impaired gametocyte (specifically male gametocyte) maturation and thus blocks transmission of malaria from human to mosquito
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gametocyte development protein 3 (MD3).